摘要
目的 :评价微创颅内血肿清除术对高血压性脑出血的临床疗效。方法 :对 78例脑出血患者随机分为治疗组 38例 ,对照组 4 0例 ,对照组应用常规内科保守治疗 ,治疗组在此基础上应用微创治疗 ,观察治疗后两组的临床疗效及并发症。结果 :有效率治疗组 86.84 % ,对照组 5 2 .5 0 % ,两组比较P <0 .0 1,差异有非常显著性意义 ,显效率治疗组 5 2 .63% ,对照组 30 .0 0 % ,两组比较P <0 .0 5 ,差异有显著性意义 .生存患者中日常生活能力及意识恢复时间 ,治疗组高于对照组 ,两组比较P <0 .0 1,差异有显著性意义。并发症发生率治疗组 17.14 % ,对照组 4 4.12 %两组比较P <0 .0 1,差异有显著性意义。结论 :微创血肿清除术治疗高血压性脑出血较单用内科保守治疗疗效好 ,并发症少 ,死亡率低 ,显著改善病人生活质量。
Object:To evaluate the clinical efficency of microlesion intracranial hematoma dissection in treating hypertensive brain hemorrhage(HBH) . Methods: 78patients were divided into two groups radomly,the control group were given the traditional therapy,while the tested group was combined with microlesion intracranial hematoma dissection. Result: the total effective rate of the tested group was 86.84%,with the complete responseof 52.63%,and that was 52.5%with CR of 30.00%in the control group,the difference was statistically significance .The incidence of complication in the tested group was 17.14%compared to 44.12% in the contral group,the death rate was 7.89%in the tested group compared to 15.00%in the contral group.the difference between them also had statistically significnce. Conclusion:Microlesion intracranial hematoma dissection combined with the tranditional therapy can increase the clinical efficency and decrease the complication,it is worthy of use in the treatment of HBH.
出处
《河北医学》
CAS
2003年第4期318-320,共3页
Hebei Medicine
关键词
微创治疗
高血压性脑出血
临床研究
并发症
Microlesion intracranial hematoma dissection
Hypertensive brain hemorrhage
Clinical study
